Atlas Trials

A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC

Clinical trial NCT06823050 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06823050
Sponsor
Xuhua Duan
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2025-03-01
Primary completion
2026-03-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.